NCT05376527 2026-04-21Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact"Oncostar" LLCPhase 1 Completed34 enrolled 18 charts
NCT01394939 2021-01-08Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaSillaJen, Inc.Phase 1/2 Completed52 enrolled 13 charts